Skip to main content
Glama

Dailymed

by io.github.pipeworx-io

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description adds significant context beyond annotations: data sources (SEC EDGAR/XBRL for companies, FAERS for drugs), handling of fiscal years, sorting by primary metric, and return format with citation URIs. No contradiction with annotations (readOnly, openWorld, idempotent, non-destructive).

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense but well-structured, starting with example triggers and then details. Every sentence is informative, though slightly verbose for a simple two-parameter tool. No wasted words.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description adequately explains return format (paired data + citation URIs) and data sources. It covers edge cases like off-calendar fiscal years. Missing minor details like error handling, but enough for correct invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, baseline 3. The description adds value by explaining how to fill the 'values' parameter per entity type (tickers/CIKs for company, names for drug) with examples, and implies array structure. This enhances understanding beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it performs side-by-side comparison of 2-5 companies or drugs in one parallel call, with examples like 'compare X and Y' or 'rank these companies'. It distinguishes from sequential single-pack lookups, making the purpose unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly instructs to 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', providing clear when-to-use guidance. It also lists example queries (e.g., 'which is bigger') that signal appropriate usage.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Dailymed toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation2/5

Multiple tools have overlapping purposes (e.g., ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded; deep_research; bet_research and multiple polymarket tools). This makes it difficult for an agent to distinguish which tool to use.

Naming Consistency4/5

Tool names consistently use snake_case and follow a verb_noun or noun_verb pattern. However, some names are very long and descriptive (e.g., polymarket_kalshi_spread, scan_competitor_ai_presence), which is acceptable but slightly inconsistent in length.

Tool Count3/5

With 38 tools, the server is on the high side of reasonable. Many are meta-tools or query routers, which inflates the count. The scope is very broad, covering diverse domains, making the number somewhat justifiable but still feeling heavy.

Completeness3/5

For the Dailymed domain, tools cover label search, retrieval, history, and comparison. However, many other domains (e.g., finance, prediction markets) rely on a handful of routing tools (ask_pipeworx) rather than dedicated tools, leaving the coverage uneven and not fully self-contained.

Resources